Tae‐Lin Ha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tae‐Lin Ha has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- In Su Lee
Center for Nanospace‐confined Chemical Reactions (NCCR) Pohang University of Science and Technology (POSTECH) Pohang South Korea
7 shared publications Jongmin Shin
Department of Applied Chemistry, College of Applied Science, Kyung Hee University, Gyeonggi-do 449-701 (Korea), Fax: (+82) 31-202-7337 http://web.khu.ac.kr/∼nanochem
4 shared publicationsGeun Ho Im
Center for Molecular and Cellular Imaging, Samsung Biomedical Research Institute
3 shared publicationsJehoon Yang
Center for Molecular and Cellular Imaging, Samsung Biomedical Research Institute
3 shared publications- Jung Hee Lee
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine and Center for Molecular and Cellular Imaging, Samsung Biomedical Research Institute, Seoul 06351, Republic of Korea
3 shared publications Choon Woo Lim
Department of Applied Chemistry, College of Applied Science, Kyung Hee University, Gyeonggi-do 449-701 (Korea), Fax: (+82) 31-202-7337 http://web.khu.ac.kr/∼nanochem
2 shared publications
Latest Publications
- Open Access
- 5 March 2014
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 25 (4) , 211-218
Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer’s disease using voxel-based analysis of amyloid plaques
In this study, we have shown the potential of a voxel-based analysis for imaging amyloid plaques and its utility in monitoring therapeutic response in Alzheimer’s disease (AD) mice using manganese oxide nanoparticles conjugated with an antibody of Aβ1-40 peptide (HMON-abAβ40). T1-weighted MR brain images of a drug-treated AD group (n=7), a nontreated AD group (n=7), and a wild-type group (n=7) were acquired using a 7.0 T MRI system before (D−1), 24-h (D+1) after, and 72-h (D+3) after injection with an HMON-abAβ40 contrast agent. For the treatment of AD mice, DAPT was injected intramuscularly into AD transgenic mice (50 mg/kg of body weight). For voxel-based analysis, the skull-stripped mouse brain images were spatially normalized, and these voxels’ intensities were corrected to reduce voxel intensity differences across scans in different mice. Statistical analysis showed higher normalized MR signal intensity in the frontal cortex and hippocampus of AD mice over wild-type mice on D+1 and D+3 (PP<0.01, uncorrected for multiple comparisons). These results were confirmed by histological analysis using a thioflavin staining. This unique strategy allows us to detect brain regions that are subjected to amyloid plaque deposition and has the potential for human applications in monitoring therapeutic response for drug development in AD.
- 5 March 2014
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 25 (4) , 211-218
Open AccessMagnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer’s disease using voxel-based analysis of amyloid plaques
In this study, we have shown the potential of a voxel-based analysis for imaging amyloid plaques and its utility in monitoring therapeutic response in Alzheimer’s disease (AD) mice using manganese oxide nanoparticles conjugated with an antibody of Aβ1-40 peptide (HMON-abAβ40). T1-weighted MR brain images of a drug-treated AD group (n=7), a nontreated AD group (n=7), and a wild-type group (n=7) were acquired using a 7.0 T MRI system before (D−1), 24-h (D+1) after, and 72-h (D+3) after injection with an HMON-abAβ40 contrast agent. For the treatment of AD mice, DAPT was injected intramuscularly into AD transgenic mice (50 mg/kg of body weight). For voxel-based analysis, the skull-stripped mouse brain images were spatially normalized, and these voxels’ intensities were corrected to reduce voxel intensity differences across scans in different mice. Statistical analysis showed higher normalized MR signal intensity in the frontal cortex and hippocampus of AD mice over wild-type mice on D+1 and D+3 (PP<0.01, uncorrected for multiple comparisons). These results were confirmed by histological analysis using a thioflavin staining. This unique strategy allows us to detect brain regions that are subjected to amyloid plaque deposition and has the potential for human applications in monitoring therapeutic response for drug development in AD.
- 9 January 2013
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 24 (1) , 16-21
Magnetic resonance imaging of amyloid plaques using hollow manganese oxide nanoparticles conjugated with antibody aβ1–40 in a transgenic mouse model
In this study, we have shown the feasibility of hollow manganese oxide nanoparticles (HMON) conjugated with an antibody of Aβ1–40 peptide (abAβ40) (HMON-abAβ40) for MRI of amyloid plaques in APP/PS1 transgenic mice. MR brain images in APP/PS1 transgenic mice and their nontransgenic littermates were acquired using a 7.0 T MRI system before, and 24 and 72 h after an injection of HMON-abAβ40. After the injection of HMON-abAβ40, we found hyperenhanced spots in the frontal cortex area on T1-weighted MR images for transgenic mice, which corresponded qualitatively to amyloid plaques detected by thioflavin-S staining. For quantitative analysis, percent MR signal changes in six brain regions (olfactory cortex, frontal cortex, cerebral cortex, thalamus, hippocampus, and cerebellar cortex) were compared between transgenic and wild-type mice. We found significant increases in the percent MR signal changes in the olfactory cortex, frontal cortex, cerebral cortex, and hippocampus, but there were no significant differences in the thalamus and cerebellar cortex for transgenic mice compared with wild-type mice. This unique strategy allowed us to detect brain regions subjected to amyloid plaque deposition in Alzheimer’s disease transgenic mouse models and has a potential to be developed for human applications, which has a current utility in preclinical research, particularly in monitoring therapeutic response for drug development in Alzheimer’s disease.
- 9 January 2013
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 24 (1) , 16-21
Magnetic resonance imaging of amyloid plaques using hollow manganese oxide nanoparticles conjugated with antibody aβ1–40 in a transgenic mouse model
In this study, we have shown the feasibility of hollow manganese oxide nanoparticles (HMON) conjugated with an antibody of Aβ1–40 peptide (abAβ40) (HMON-abAβ40) for MRI of amyloid plaques in APP/PS1 transgenic mice. MR brain images in APP/PS1 transgenic mice and their nontransgenic littermates were acquired using a 7.0 T MRI system before, and 24 and 72 h after an injection of HMON-abAβ40. After the injection of HMON-abAβ40, we found hyperenhanced spots in the frontal cortex area on T1-weighted MR images for transgenic mice, which corresponded qualitatively to amyloid plaques detected by thioflavin-S staining. For quantitative analysis, percent MR signal changes in six brain regions (olfactory cortex, frontal cortex, cerebral cortex, thalamus, hippocampus, and cerebellar cortex) were compared between transgenic and wild-type mice. We found significant increases in the percent MR signal changes in the olfactory cortex, frontal cortex, cerebral cortex, and hippocampus, but there were no significant differences in the thalamus and cerebellar cortex for transgenic mice compared with wild-type mice. This unique strategy allowed us to detect brain regions subjected to amyloid plaque deposition in Alzheimer’s disease transgenic mouse models and has a potential to be developed for human applications, which has a current utility in preclinical research, particularly in monitoring therapeutic response for drug development in Alzheimer’s disease.
- 8 November 2012
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 135 (4) , 1378-1385
Reversible and Cyclical Transformations between Solid and Hollow Nanostructures in Confined Reactions of Manganese Oxide and Silica within Nanosized Spheres
Annealing of [email protected]2 nanospheres in a reducing gas environment resulted in the transformation of the core–shell structure into a hollow structure as a result of outward diffusion of MnO species into the thermodynamically more stable silicate phase. When the hollow silicate nanospheres were oxidized, the interior cavities were refilled with a Mn3O4 phase segregated from the silicate phase, and the hollow structure reverted to the initial core–shell structure. More interestingly, when catalytically active Pt nanocrystals were introduced into the manganese oxide/silica system, the Mn3O4 was readily reduced to the chemically reactive MnO, even at low temperature, which enabled reconversion of the solid nanospheres with a Mn3O4 core to hollow nanostructures during reductive annealing. Therefore, when [email protected]2/Pt(II) nanospheres were subjected to an oxidation/reduction cycle by repeatedly switching the flowing gas between air and hydrogen, the nanospheres underwent a reversible change between solid and hollow structures, depending on the gas environment. The solid-to-hollow-to-solid transformation was successfully cycled many times simply by repeatedly switching the flowing gas during annealing.
- 8 November 2012
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 135 (4) , 1378-1385
Reversible and Cyclical Transformations between Solid and Hollow Nanostructures in Confined Reactions of Manganese Oxide and Silica within Nanosized Spheres
Annealing of [email protected]2 nanospheres in a reducing gas environment resulted in the transformation of the core–shell structure into a hollow structure as a result of outward diffusion of MnO species into the thermodynamically more stable silicate phase. When the hollow silicate nanospheres were oxidized, the interior cavities were refilled with a Mn3O4 phase segregated from the silicate phase, and the hollow structure reverted to the initial core–shell structure. More interestingly, when catalytically active Pt nanocrystals were introduced into the manganese oxide/silica system, the Mn3O4 was readily reduced to the chemically reactive MnO, even at low temperature, which enabled reconversion of the solid nanospheres with a Mn3O4 core to hollow nanostructures during reductive annealing. Therefore, when [email protected]2/Pt(II) nanospheres were subjected to an oxidation/reduction cycle by repeatedly switching the flowing gas between air and hydrogen, the nanospheres underwent a reversible change between solid and hollow structures, depending on the gas environment. The solid-to-hollow-to-solid transformation was successfully cycled many times simply by repeatedly switching the flowing gas during annealing.
- Open Access
- 22 December 2011
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 7 (1) , 1
Cover Picture: Seed‐mediated Growth of Gold inside Hollow Silica Nanospheres for Sensing Peroxide and Glucose Concentrations (Chem. Asian J. 1/2012)
- 22 December 2011
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 7 (1) , 1
Open AccessCover Picture: Seed‐mediated Growth of Gold inside Hollow Silica Nanospheres for Sensing Peroxide and Glucose Concentrations (Chem. Asian J. 1/2012)
- 5 September 2011
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 7 (1) , 36-39
Seed‐mediated Growth of Gold inside Hollow Silica Nanospheres for Sensing Peroxide and Glucose Concentrations
- 5 September 2011
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 7 (1) , 36-39
Seed‐mediated Growth of Gold inside Hollow Silica Nanospheres for Sensing Peroxide and Glucose Concentrations
- 15 July 2011
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 47 (32) , 9176-9178
Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform
A platform protocol developed based on the hollow manganese oxide nanoparticles provided multimodal diagnostic agents, which allow the selectively detect vulva cancer with T1-weighted in vivo MRI.
- 15 July 2011
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 47 (32) , 9176-9178
Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform
A platform protocol developed based on the hollow manganese oxide nanoparticles provided multimodal diagnostic agents, which allow the selectively detect vulva cancer with T1-weighted in vivo MRI.
- 12 January 2010
- Published by Wiley in European Journal of Inorganic Chemistry
- Vol. 2010 (3) , 357-360
Generation of Hollow MnSiO3 Nanostructures through the Solid‐State Reaction of Mn3O4 and Pd/PdO Nanocrystals Dimensionally Confined within Nanosized Silica Spheres
- 12 January 2010
- Published by Wiley in European Journal of Inorganic Chemistry
- Vol. 2010 (3) , 357-360
Generation of Hollow MnSiO3 Nanostructures through the Solid‐State Reaction of Mn3O4 and Pd/PdO Nanocrystals Dimensionally Confined within Nanosized Silica Spheres